Jonathan Lambourne
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Antifungal resistance and susceptibility
- Modeling and Simulation top 2%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 6
- Antifungal resistance and susceptibility 5
- Epidemiology 16
- Nail Diseases and Treatments 4
- Fungal Infections and Studies 3
- Infective Endocarditis Diagnosis and Management 3
- Cytomegalovirus and herpesvirus research 3
- Co-authors
- Teresa Cutiño‐Moguel (2 shared papers)Mahdad Noursadeghi (1 shared paper)João B. Augusto (1 shared paper)Maudrian Burton (1 shared paper)Áine McKnight (1 shared paper)James Moon (1 shared paper)Charlotte Manisty (1 shared paper)Xosé Couto‐Parada (1 shared paper)
- Journals
- Journal of Medical Microbiology (3 papers)The Lancet Microbe (2 papers)Eurosurveillance (2 papers)Clinical Infectious Diseases (2 papers)Science (2 papers)
- Partner nations
- United KingdomFranceCanada
In The Last Decade
Jonathan Lambourne
36 papers receiving 1.6k citations
Jonathan Lambourne's Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 1.2k
- Modeling and Simulation 145
- Immunology 273
- Health 82
- Neurology 120
Countries citing papers authored by Jonathan Lambourne
This map shows the geographic impact of Jonathan Lambourne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lambourne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lambourne more than expected).
Fields of papers citing papers by Jonathan Lambourne
This network shows the impact of papers produced by Jonathan Lambourne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lambourne. The network helps show where Jonathan Lambourne may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Lambourne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 Hit paper breakdown → | 2021 | 309 |
| 2 | Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure Hit paper breakdown → | 2022 | 255 |
| 3 | 2021 | 249 | |
| 4 | 2020 | 224 | |
| 5 | 2020 | 159 | |
| 6 | 2017 | 69 | |
| 7 | 2009 | 67 | |
| 8 | 2021 | 48 | |
| 9 | 2021 | 48 | |
| 10 | 2020 | 46 | |
| 11 | 2021 | 30 | |
| 12 | 2018 | 27 | |
| 13 | 2020 | 23 | |
| 14 | 2006 | 22 | |
| 15 | 2021 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2006 | 10 | |
| 18 | 2019 | 9 | |
| 19 | 2025 | 8 | |
| 20 | 2017 | 7 |
About Jonathan Lambourne
Jonathan Lambourne is a scholar working on Infectious Diseases, Epidemiology, Immunology, Clinical Biochemistry and Oncology, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers), Antifungal resistance and susceptibility (5 papers), Nail Diseases and Treatments (4 papers), Fungal Infections and Studies (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Infective Endocarditis Diagnosis and Management (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Modeling and Simulation (145 citations), Immunology (273 citations), Health (82 citations) and Neurology (120 citations). Jonathan Lambourne has collaborated with scholars based in United Kingdom, France and Canada. Frequent co-authors include Teresa Cutiño‐Moguel, Mahdad Noursadeghi, João B. Augusto, Maudrian Burton, Áine McKnight, James Moon, Charlotte Manisty, Xosé Couto‐Parada, Thomas Alexander Treibel and Holly Ciesielczuk. Their work appears in journals such as Journal of Medical Microbiology, The Lancet Microbe, Eurosurveillance, Clinical Infectious Diseases and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.